Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
2.
Br J Dermatol ; 182(2): 434-443, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31111470

RESUMO

BACKGROUND: Genotype-phenotype studies can identify subgroups of patients with specific clinical features or differing outcomes, which can help shape management. OBJECTIVES: To characterize the frequency of different causative genotypes in congenital melanocytic naevi (CMN), and to investigate genotype-phenotype and genotype-outcome associations. METHODS: We conducted a large cohort study in which we undertook MC1R genotyping from blood, and high-sensitivity genotyping of NRAS and BRAF hotspots in 156 naevus biopsies from 134 patients with CMN [male 40%; multiple CMN 76%; projected adult size (PAS) > 20 cm, 59%]. RESULTS: Mosaic NRAS mutations were detected in 68%, mutually exclusive with BRAF mutations in 7%, with double wild-type in 25%. Two separate naevi were sequenced in five of seven patients with BRAF mutations, confirming clonality. Five of seven patients with BRAF mutations had a dramatic multinodular phenotype, with characteristic histology distinct from classical proliferative nodules. NRAS mutation was the commonest in all sizes of CMN, but was particularly common in naevi with PAS > 60 cm, implying more tolerance to that mutation early in embryogenesis. Facial features were less common in double wild-type patients. Importantly, the incidence of congenital neurological disease, and apparently of melanoma, was not altered by genotype; no cases of melanoma were seen in BRAF-mutant multiple CMN, however, this genotype is rare. CONCLUSIONS: CMN of all sizes are most commonly caused by mutations in NRAS. BRAF is confirmed as a much rarer cause of multiple CMN, and appears to be commonly associated with a multinodular phenotype. Genotype in this cohort was not associated with differences in incidence of neurological disease in childhood. However, genotyping should be undertaken in suspected melanoma, for guidance of treatment. What's already known about this topic? Multiple congenital melanocytic naevi (CMN) have been shown to be caused by NRAS mosaic mutations in 70-80% of cases, by BRAF mosaicism in one case report and by inference in some previous cases. There has been debate about genotypic association with different sizes of CMN, and no data on genotype-outcome. What does this study add? NRAS mosaicism was found in 68%, BRAF in 7% and double wild-type in 25% of cases of CMN. NRAS was the commonest mutation in all sizes of CMN, but was nearly universal in projected adult size > 60 cm. BRAF is often associated with a distinct multinodular clinical/histological phenotype. Adverse outcomes did not differ between genotypes on current numbers.


Assuntos
Nevo Pigmentado , Neoplasias Cutâneas , Adulto , Estudos de Coortes , Genótipo , Humanos , Masculino , Mutação/genética , Nevo Pigmentado/genética , Fenótipo , Proteínas Proto-Oncogênicas B-raf/genética , Neoplasias Cutâneas/genética
3.
Cancer Genet Cytogenet ; 164(1): 54-60, 2006 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-16364763

RESUMO

Solid pseudopapillary neoplasm of the pancreas (SPNP) is a rare tumor with low malignant potential found in adolescent girls and young women. The pathogenesis of SPNP remains uncertain and its management is controversial. Genetic changes associated with SPNP have seldom been reported. We describe here the cytogenetic investigation of a case of SPNP in a 13-year-old girl whose tumor cells revealed two unrelated clones: one clone characterized by complex karyotypic changes, including breakpoints in two common fragile sites at chromosome 2, band q33, and chromosome 4, band q31, and the second clone defined by partial monosomy for chromosome X. Loss of heterozygosity for HRAS was also identified by array comparative genomic hybridization (a-CGH). These cumulative changes seem insufficient for activation of cell transformation, but could possibly play a role in priming the cell for future mutagenic events.


Assuntos
Aberrações Cromossômicas , Neoplasias Pancreáticas/genética , Adolescente , Feminino , Humanos , Hibridização in Situ Fluorescente , Cariotipagem , Perda de Heterozigosidade , Hibridização de Ácido Nucleico
4.
Br J Haematol ; 105(3): 684-9, 1999 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-10354132

RESUMO

The t(12;21) is the commonest recurrent translocation in childhood acute lymphoblastic leukaemia (ALL), the presence of which has been suggested to be a good prognostic feature. We have studied 22 childhood cases of B-precursor ALL with this rearrangement, and have found no significant differences in event-free survival between these and a control group of patients with similar phenotypes. Using a variety of cytogenetic and molecular techniques, we have confirmed a strong association with co-expression of myeloid markers, frequent deletions of the short-arm of the untranslocated chromosome 12 homologue and duplication of the derivative chromosome 21. Intragenic deletion of the untranslocated ETV6 gene in 3/12 informative patients points to the likelihood of this gene being a target for deletion.


Assuntos
Cromossomos Humanos Par 12/genética , Cromossomos Humanos Par 21/genética , Leucemia-Linfoma Linfoblástico de Células Precursoras B/genética , Leucemia-Linfoma Linfoblástico de Células Precursoras/genética , Translocação Genética/genética , Criança , Pré-Escolar , Intervalo Livre de Doença , Feminino , Rearranjo Gênico , Humanos , Cariotipagem , Perda de Heterozigosidade , Masculino , Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos
5.
World Health Forum ; 16(2): 194-5, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-7794465

RESUMO

The decline of Viet Nam's once highly effective commune health stations has resulted in the over-prescription of drugs and the danger of lower public health standards. It must be recognized that private and public activities form part of the same health system, and need firm supervision if it is to flourish.


Assuntos
Prescrições de Medicamentos/normas , Programas Nacionais de Saúde/normas , Qualidade da Assistência à Saúde , Prescrições de Medicamentos/economia , Programas Nacionais de Saúde/economia , Vietnã
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA